Sign in
Join
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
My Account
orders
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
Home
About Us
Privacy Policy
Disclaimer
Advertise On Market Exclusive
Sitemap
Submit a Scoop!
Contact Us
Stock Market News
Stocks
Analyst Ratings
Insider Trading
SEC Filings
Earnings
Biotech Stocks
Small Caps
Blockchain & Cryptocurrency
Become a Contributor!
Home
Tags
NASDAQ:ZYNE
Tag: NASDAQ:ZYNE
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
May 31, 2018
0
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
March 23, 2018
0
Analyst Activity – Ladenburg Thalmann Financial Services Initiates Coverage On Zynerba...
ME Staff
-
January 29, 2018
0
Insider Trading Activity Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) – Major Shareholder Bought...
ME Staff
-
January 3, 2018
0
Biotech Movers: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and PTC Therapeutics, Inc. (NASDAQ:PTCT)
ME Contributor
-
September 29, 2017
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Reports Third Quarter 2016...
ME Staff
-
November 14, 2016
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K Announces Initiation of STAR...
ME Staff
-
November 2, 2016
0
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) Files An 8-K
ME Staff
-
October 18, 2016
0
// AST – IMS - [MarketExclusive_ROS]
